Taoka Chemical Company, Limited (TYO:4113)
Japan · Delayed Price · Currency is JPY 1,095.00
-5.00 (-0.45%)
At close: Feb 6, 2026
Taoka Chemical Company Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 32,930 | 29,930 | 28,544 | 30,166 | 32,374 | 32,057 | |
Revenue Growth (YoY) | 11.88% | 4.86% | -5.38% | -6.82% | 0.99% | 24.88% |
Cost of Revenue | 26,948 | 24,439 | 23,966 | 26,166 | 26,052 | 24,840 |
Gross Profit | 5,982 | 5,491 | 4,578 | 4,000 | 6,322 | 7,217 |
Selling, General & Admin | 2,913 | 2,792 | 2,645 | 2,712 | 2,706 | 2,418 |
Research & Development | 812 | 812 | 858 | 837 | 907 | 783 |
Operating Expenses | 3,725 | 3,604 | 3,503 | 3,549 | 3,613 | 3,201 |
Operating Income | 2,257 | 1,887 | 1,075 | 451 | 2,709 | 4,016 |
Interest Expense | -4 | -6 | -9 | -8 | -2 | -3 |
Interest & Investment Income | 30 | 22 | 19 | 27 | 25 | 22 |
Currency Exchange Gain (Loss) | -9 | 25 | 14 | -40 | -3 | - |
Other Non Operating Income (Expenses) | 10 | 19 | 27 | 8 | 53 | 15 |
EBT Excluding Unusual Items | 2,284 | 1,947 | 1,126 | 438 | 2,782 | 4,050 |
Gain (Loss) on Sale of Investments | - | - | - | 26 | - | - |
Gain (Loss) on Sale of Assets | 17 | 17 | 14 | 19 | 16 | 12 |
Asset Writedown | -12 | -19 | -13 | -6 | -30 | -399 |
Other Unusual Items | 103 | 18 | - | - | - | -1 |
Pretax Income | 2,288 | 1,963 | 1,127 | 477 | 2,768 | 3,662 |
Income Tax Expense | 575 | 485 | 307 | 167 | 705 | 1,047 |
Net Income | 1,713 | 1,478 | 820 | 310 | 2,063 | 2,615 |
Net Income to Common | 1,713 | 1,478 | 820 | 310 | 2,063 | 2,615 |
Net Income Growth | 34.04% | 80.24% | 164.52% | -84.97% | -21.11% | 37.85% |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 | 14 |
Shares Change (YoY) | -0.00% | 0.01% | - | - | 0.02% | -0.03% |
EPS (Basic) | 119.55 | 103.15 | 57.23 | 21.64 | 143.98 | 182.55 |
EPS (Diluted) | 119.55 | 103.15 | 57.23 | 21.64 | 143.98 | 182.55 |
EPS Growth | 34.03% | 80.23% | 164.52% | -84.97% | -21.13% | 37.90% |
Free Cash Flow | - | 2,971 | 2,496 | -2,841 | -3,371 | 3,162 |
Free Cash Flow Per Share | - | 207.34 | 174.20 | -198.28 | -235.27 | 220.73 |
Dividend Per Share | 40.000 | 31.000 | 18.000 | 27.000 | 36.000 | 32.000 |
Dividend Growth | 122.22% | 72.22% | -33.33% | -25.00% | 12.50% | 33.33% |
Gross Margin | - | 18.35% | 16.04% | 13.26% | 19.53% | 22.51% |
Operating Margin | 6.85% | 6.30% | 3.77% | 1.49% | 8.37% | 12.53% |
Profit Margin | 5.20% | 4.94% | 2.87% | 1.03% | 6.37% | 8.16% |
Free Cash Flow Margin | - | 9.93% | 8.74% | -9.42% | -10.41% | 9.86% |
EBITDA | 3,761 | 3,374 | 2,539 | 1,913 | 4,183 | 5,508 |
EBITDA Margin | - | 11.27% | 8.89% | 6.34% | 12.92% | 17.18% |
D&A For EBITDA | 1,504 | 1,487 | 1,464 | 1,462 | 1,474 | 1,492 |
EBIT | 2,257 | 1,887 | 1,075 | 451 | 2,709 | 4,016 |
EBIT Margin | - | 6.30% | 3.77% | 1.49% | 8.37% | 12.53% |
Effective Tax Rate | - | 24.71% | 27.24% | 35.01% | 25.47% | 28.59% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.